Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
Rdos. 2024 vs 2023: Ventas: 81,73 M euros (+27,7% vs +25,4% BS(e)); EBITDA: 42,06 M euros (+23,3% vs +27,0% BS(e)); EBIT: 24,16 M euros (); BDI: 12,11 M euros (+1,0% vs -34,6% BS(e)).
NEWS SUMMARY: ARCELORMITTAL, ECOENER, ENDESA, OHLA. Moderate drops in a session without volume and with weaker macro data Despite the US rally seen last Friday after the European closing bell, in the absence of additional catalysts, the worse macroeconomic data released yesterday in the US dragged down European stock markets in a session with low volume. Thus, in the STOXX 600 Pharma stood out thanks to the rally of Novo Nordisk following last Friday’s strong corrections whereas Leisure and Autos were the worst performers, with Volkswagen being hit by the disappointing agreement reached with ...
1Q'25 vs. 1Q'24 Results Sales: € 372.5 M (-11.2% vs. -6.6% BS(e)); EBITDA: € 104.6 M (-4.7% vs. -5.3% BS(e)); Net Profit: € 47.6 M (-9% vs. +7% BS(e));
1Q'25 vs. 1Q'24 Results Sales: € 1.206 Bn (+7.9% vs. +6.6% BS(e) and +6.4% consensus);
1Q'25 vs. 1Q'24 Results Total Revenues: € 77.6 M (-44.6% vs. -42.9% BS(e)); Pre-sales: € 170 M (+2% vs. 0% BS(e));
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.